Effect of TAK-085 on Low-density Lipoprotein Particle Size in Patients with Hypertriglyceridemia: A Double-blind Randomized Clinical Study

Efficacy and safety of TAK-085 compared with eicosapentaenoic acid in Japanese subjects with hypertriglyceridemia undergoing lifestyle modification: The omega-3 fatty acids randomized double-blind (ORD) study

(2013) Ichiro Tatsuno et al.   Journal of Clinical Lipidology

Effects of prescription omega-3-acid ethyl esters, coadministered with atorvastatin, on circulating levels of lipoprotein particles, apolipoprotein CIII, and lipoprotein-associated phospholipase A2 mass in men and women with mixed dyslipidemia

(2011) Kevin C. Maki et al.   Journal of Clinical Lipidology

Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: A review

(2011) Terry A. Jacobson et al.   Journal of Clinical Lipidology

Catabolism of lipoproteins and metabolic syndrome

(2009) Patrice Therond   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

Effects of prescription omega-3-acid ethyl esters on lipoprotein particle concentrations, apolipoproteins AI and CIII, and lipoprotein-associated phospholipase A2 mass in statin-treated subjects with hypertriglyceridemia

(2009) Michael H. Davidson et al.   Journal of Clinical Lipidology

Effects of Adding Prescription Omega-3 Acid Ethyl Esters to Simvastatin (20 mg/day) on Lipids and Lipoprotein Particles in Men and Women With Mixed Dyslipidemia

(2008) Kevin C. Maki et al.   AMERICAN JOURNAL OF CARDIOLOGY